Invention Grant
- Patent Title: Antibody to human IL-1 beta
- Patent Title (中): 人IL-1β的抗体
-
Application No.: US14072165Application Date: 2013-11-05
-
Publication No.: US09404930B2Publication Date: 2016-08-02
- Inventor: Stefanie Grabulovski , Titus Kretzschmar , Simone Schmitt , Abdijapar Shamshiev , Thorsten Alexander Schäfer
- Applicant: Delenex Therapeutics AG
- Applicant Address: CH Schlieren
- Assignee: DELENEX THERAPEUTICS AG
- Current Assignee: DELENEX THERAPEUTICS AG
- Current Assignee Address: CH Schlieren
- Agency: Elmore Patent Law Group, P.C.
- Agent Carolyn S. Elmore, Esq.; Darlene A. Vanstone
- Priority: EP12007503 20121105
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/24 ; G01N33/68 ; A61K39/00
Abstract:
The present invention relates to anti-IL-1 beta binding members and in particular to monovalent high potency IL-1 beta-binding antibody fragments being highly stable and soluble. Such binding members may be used in the treatment of inflammatory and other diseases as well as in diagnostics. Also provided are related nucleic acids, vectors, cells, and compositions.
Public/Granted literature
- US20140134183A1 BINDING MEMBERS TO IL-1 BETA Public/Granted day:2014-05-15
Information query
